Dani Bancroft, Author at Labiotech.eu

About

Former Editor, now flitting back and forth as a freelancer. Originally from London and studied Zoology at the University of Reading, UK. Previous work includes having written for The Spark University Newspaper and the Wellcome Trust.

Articles by Dani Bancroft

News and Trends 11 Sep 2015

Biom’Up funding goes up Up UP! Surgery tech gets new pot of €31.3M VC

Biom’Up is a Lyon (Fr) Med-tech company which produces biopolymer devices to improve surgery. Launch of their new product Hemoblast has triggered a series C investment round from a large syndicate of European venture capitals. Biom’Up was founded in 2005, experiencing exponential growth since with their biopolymer tech development which achieved a €3M turnover in […]

September 11, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 10 Sep 2015

Roche adds AveXis to its SMA portfolio – determined to dominate market

Swiss Roche is looking to dominate market in Spinal Muscular Atrophy (SMA) research, now also investing in AveXis as part of €58M series D investment in their SMA one-time treatment pipeline. Other veteran VC parties include Deerfield Management and Venrock, with new investors also looking to claim a stake in AveXis SMA candidate treatment. SMA […]

September 10, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 10 Sep 2015

Genkyotex’ NOX inhibitor candidate Fails to follow through on Phase II

The French biotech Genkyotex has announced Phase II results for GKT137831 in diabetic kidney disease. The NOX1-4 inhibitor failed to reduce albuminuria. Genkyotex focuses on developing inhibitors of nicotinamide adenine dinucleotide phosphate-oxidase (NADPH) enzymes which are expressed by the NOX-gene family (NOX 1-5). NOX enzymes generate reactive oxidative species (ROS) which if overproduced, can cause […]

September 10, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 10 Sep 2015

Debiopharm teams up with Solid Biosciences to treat DMD

The Debiopharm Group, headquartered in Lausanne (Switzerland) has announced its Alisporovir brand will under-go preclinical trials to treat Duchenne Muscular Dystrophy (DMD) in collaboration with Solid Biosciences, a Cambridge (MA) biotech dedicated to research of DMD. The Debiopharm Group has been around for over 40 years, with 4 international subsidiary companies within the Swiss-based group. […]

September 10, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 9 Sep 2015

Encouraging results from Tedopi Phase II trials in patients with brain metastases

French Immuno-oncology Biotech OSE Pharma has announced its phase II results for Tedopi trials showing outcome for patients with brain metastases. Announced at the World Conference on Lung Cancer in Denver (US), OSE Pharma revealed how Tedopi had shown interesting results in patients diagnosed with brain metastases from advanced non-small cell lung cancer. Advanced non-small […]

September 9, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 9 Sep 2015

FDA will use a European Bioinformatics tool to keep patients safe

Molecular Health, a bioinformatics company based in Heidelberg, Germany, today announced that it will enter a commercial-licensing agreement with the US Food and Drugs Standard Agency (FDA) to implement their new bioanalytical product SafetyMAP to analyse risk of marketed drugs. Molecular Health (Labiotech Map Profile here), partnered with MD Anderson (TX) early on, doing consultancy […]

September 9, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 9 Sep 2015

Kymab: One Multi-Award Winning Biotech Company Worth Watching!

Kymab is the European biotech to watch! Based in Cambridge (UK), the company has developed the Kymouse platform, with a unique approach to antibody delivery that has allowed this biotech to advance drug and vaccine discovery in a range of key medical research areas including HIV, malaria, cancers and autoimmune diseases. Kymab’s golden egg lies in the […]

September 9, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 8 Sep 2015

Major EU VCs invest €36.6M into Mallorcan hemodyalisis treatment

Ysios Capital is the leading investor on Baleric Island based Sanifit (Spain) which has developed a new candidate looking to treat Calciphylaxis and patients with renal diseases requiring hemodyalysis. Other lead VCs are looking to also invest, with interest from Forbion Partners (Nl) and Edmond de Rothschild (Fr) to name a few. Its series C […]

September 8, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 7 Sep 2015

Biotech Crowdfunding in Europe: Trendy but only 0.2% of total VC money raised since 2010

Figures for the amount raised for EU biotechs since 2010 suggest although crowdfunding is considered a massive springboard for small startups, in reality, it has a much more limited range of use. Perhaps we have too high an ambition for crowdfunding as a financial tool for biotech? Crowdfunding is in the general media so often […]

September 7, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 7 Sep 2015

A Slice of Europe: MD Anderson looks to invest in EU Immuno-Oncology

MD Anderson is expanding its Immatics sharehold to spawn new Houston-based subsidiary Immatics US through investing into a $60M (€54M) pot. Also partnering up with French CAR-T pioneers Cellectis, and collaborating with German Merck, MD Anderson is seemingly wanting to immerse itself in the European immuno-oncology field. As a shareholder in the German cancer immunotherapy […]

September 7, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 5 Sep 2015

Top 5 Things you need to know from outside the EU this week: (Truvada, Nanoclews, CRISPR-Cas9)

Oh hey there…another Top 5 topics you need to know from outside Europe this week. Enjoy and if you have time, give us some feedback! BREAKTHROUGH TABLET PREVENTS HIV INFECTION IN UP TO 92% OF HIGH RISK CASES HIV Tablet ‘Truvada‘: San Francisco health Insurance firm Kaiser Permanente published a study on Tuesday showed out of the […]

September 5, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 4 Sep 2015

Sweden, Vegan and GMO-Free? Check out Simris Alg for your Omega-3

By running an innovative microalgae farm in Hammenhög, Sweden, Simris Alg produces a vegan and GMO-free Omega-3 fatty acid alternative to oily fish derivatives for industry. This Swedish start-up is winning all kinds of awards for their almost too-good-to-be-true approach to dietary Omega-3 oils. The Swedish entrepreneur Fredrika Gullfot (CEO) has improved upon a sustainable alternative to producing Omega-3 oils through a pioneering […]

September 4, 2015 - 3 minutesmins - By Dani Bancroft

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Dani Bancroft

About

Articles by Dani Bancroft

Biom’Up funding goes up Up UP! Surgery tech gets new pot of €31.3M VC

Roche adds AveXis to its SMA portfolio – determined to dominate market

Genkyotex’ NOX inhibitor candidate Fails to follow through on Phase II

Debiopharm teams up with Solid Biosciences to treat DMD

Encouraging results from Tedopi Phase II trials in patients with brain metastases

FDA will use a European Bioinformatics tool to keep patients safe

Kymab: One Multi-Award Winning Biotech Company Worth Watching!

Major EU VCs invest €36.6M into Mallorcan hemodyalisis treatment

Biotech Crowdfunding in Europe: Trendy but only 0.2% of total VC money raised since 2010

A Slice of Europe: MD Anderson looks to invest in EU Immuno-Oncology

Top 5 Things you need to know from outside the EU this week: (Truvada, Nanoclews, CRISPR-Cas9)

Sweden, Vegan and GMO-Free? Check out Simris Alg for your Omega-3

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Dani Bancroft

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!